| Tag | Content |
|---|
EnhancerAtlas ID | HS176-43431 | Organism | Homo sapiens | Tissue/cell | SK-N-SH | Coordinate | chrX:46629430-46630710 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_33957 | chrX:46629704-46630998 | HCC1954 |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH0XI046769 | chrX | 46629319 | 46631219 |
| Enhancer Sequence | TTTTGTCAGC TGCTTTATTA CCTCCAAACC AGAGCTGTTC ATTTTTTATT CTATTTCCAA 60
AAACCAAATA TCCCTCCCAA GTCAATTTCA AAATATAATC TTAGTTCAGA TTCTCTAGAA 120
CAAAAGCAAA GTCATTTCTA GGCACTCATA GTTTTGTTTT ATGTTTCTCA TTATGCACAT 180
TGAGATTCCT CTAAATGTGA GTCATTTAAG CAAAACCTTG GGAAACCTCC AGATTCCTTT 240
TTAATTATCT TAAATTCATC TGAAAATATT TCAGCAAATG CAGGAGAGAA TGCCCTTATT 300
AGCAAGATGT TTTAAAATCA AGAAGAGCCT ATTATGAACT CAAGATACTC CCTAAAGGTT 360
TTATTAACAG TTCAGGATTG TCCCTTCTAT CTGCCTGTTC CTGTCTCACT ACAGATAGCA 420
AAATGTAGGA ATTGCAGTTT TTAGCTCCTT TTAGCATCTT CCAGATTTGG GCTTCCATCC 480
AAGCTCCCAC TGCAGTGCAC CACTCTGTGA GTCGATGACA GGCAAGGTCG AACAGCCCCT 540
GGGGAACCTT CGCAGATGTG TTGAATACCA TAAACATAAA TAGATAATCC TTATCTTAAA 600
GCAAGAGAGG CAGAAAGACA CGGAGAAGAC CCAGGCACCC TTGCCTTCAT GTCTGTACAG 660
ACCCACATGG ACTGTATGTT TAGGATTCAG TAGCCATGTT AGAAAAATGC TACCTCAGAC 720
CCTATTCAGG GTTAGCTACA GTAACCTTAG GAGTCCCTTC TGATCATCCT CTTCCCATGG 780
CAGCTGCAAA CTTTTGCCTC TGCCATGTAT GGGAAAATTG ATCACTTAAA AGGAACTCTT 840
AAGGTTTATT AGAAATGCTT TTGCTGTAAG TGGCAGAAAA CCTGCTCCCA AAGACTGAAG 900
TGAGTAAGAC TTTATCTTGC TCATATAACA GGCATTCTCT CAGTAGGAAA CCACCAGCTC 960
AGTGACTCAA GGATGTAACA CGACTCAAGG ATGCAATCCT AACATGCCAA GCTGTTAGGA 1020
TTGAGAAAGA GATACTGCAA CTGGAAACAT CAGGTATAGG TTTAGAGCAG GGAAAAGTGG 1080
GAAGGGCCCT GCAGCCTCTC TCCTTTTATC AAGAAGGTGA AAGCTTCCTC AACCCTATCT 1140
CCCTGAGGCT CAGCCAACTC CTGTTTGGAT CTCATTGCCC AGAACTTGAT TAAGTGGCCA 1200
CCTCTGGCTG CAAGAGAGGC TGGAAAAATG GGGAACAGTT TGTCACAATT GGCTTGGTGC 1260
AGTTGCAAGA CATTGCCTGG 1280
|
| |
|
|
|
